Pharmacy

Dr. Nele Jessel, athenahealth's CMO and Dr. Andrew Mellin, Surescripts' VP and CMIO, said that real-time prescription benefit data has helped patients avoid sticker shock, save money and pick up 8% more scripts across athena's prescribers.  

Also, South Australia is introducing free virtual mental health support for young people.

Tx-LLM was fine-tuned from Google's Med-PaLM 2 and created to analyze a variety of chemical or biological entities to assist with the drug-discovery pipeline.  

Using the FHIR standard can help organizations like the VA connect rapidly to drug data, which paves the way for real-time surveillance that improves patient safety and identifies adverse events tied to medication.

Videha Sharma, clinical innovation lead at the University of Manchester, explains the NHS’s plan to expand pharmacogenetics, or how people’s genetic codes influence the effects of drugs, beyond specialist care to general practice.

Efforts are being made to find ways to notify clinicians about possible medication errors without overloading them. First Databank director of product management Anna Dover and NCH Healthcare System CMIO Dr. David Linz explain.  

Through volunteer work after the 2020 Beirut explosion, Marina El Khawand, founder and president of Medonations, describes how getting a patient in dire need of her inhaler evolved into starting an NGO that crowdsources medications for Lebanese patients.

Project Asclepius aims to modernize meds processes that are too often still manual, say leaders from Cleveland Clinic London and other organizations working to help providers streamline their pharmacies to boost patient safety and gain cost efficiencies.  

An American Hospital Association report, sponsored by Amazon Business, found 60% of respondents experience drug shortages. Bill Kopitke, head of healthcare at Amazon Business, offers more perspective.  

As he describes what's in store for the company in 2024, Dr. Peter Bonis discusses its recent survey on consumer concerns around artificial intelligence and its acquisition of Invistics.